Growing community of inventors

Mainz, Germany

Edgar Schmitt

Average Co-Inventor Count = 4.61

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Edgar SchmittHelmut Jonuleit (2 patents)Edgar SchmittChristian Becker (2 patents)Edgar SchmittTobias Bopp (2 patents)Edgar SchmittFranz-Josef Schneider (2 patents)Edgar SchmittHorst Kunz (1 patent)Edgar SchmittNikola Gaidzik (1 patent)Edgar SchmittNatascha Stergiou (1 patent)Edgar SchmittEdgar Schmitt (3 patents)Helmut JonuleitHelmut Jonuleit (9 patents)Christian BeckerChristian Becker (4 patents)Tobias BoppTobias Bopp (2 patents)Franz-Josef SchneiderFranz-Josef Schneider (2 patents)Horst KunzHorst Kunz (8 patents)Nikola GaidzikNikola Gaidzik (1 patent)Natascha StergiouNatascha Stergiou (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universitätsmedizin Der Johannes Gutenberg-Universitat Mainz (2 from 15 patents)

2. Other (1 from 832,912 patents)

3. Johannes Gutenberg-Universität Mainz (44 patents)


3 patents:

1. 12084511 - Peptide-based compounds for use in the prevention, treatment and/or detection of cancer

2. 10729742 - Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4

3. 8557533 - Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…